Erschienen in:
07.12.2023 | Hepatobiliary Tumors
Utilization of Multiorgan Radiomics to Predict Future Liver Remnant Hypertrophy After Portal Vein Embolization: Another Tool for the Toolbox?
verfasst von:
Matthew E. B. Dixon, MD, FACS, Sam G. Pappas, MD, FACS
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 2/2024
Einloggen, um Zugang zu erhalten
Excerpt
Indications for hepatic resection have continued to expand with improvements in understanding of intrahepatic anatomy, advancement in surgical technology and technique, as well as improvement in anesthetic techniques and postoperative care. Partial hepatectomy often is considered for patients with primary malignancies (such as hepatocellular carcinoma and intrahepatic and perihilar cholangiocarcinoma) as well as secondary malignancies (such as colorectal liver metastases (CRCLM) and metastatic neuroendocrine tumor). While parenchymal-sparing operative strategies are prioritized when appropriate and feasible, major hepatic resections are still often required to treat these conditions. …